Works matching AU Ie Byung Park


Results: 39
    1

    Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge.

    Published in:
    2019
    By:
    • Choi, In Suck;
    • Park, Ie Byung;
    • Lee, Kiyoung;
    • Ahn, Tae Hoon;
    • Kim, Ju Han;
    • Ahn, Youngkeun;
    • Chae, Sung-Chull;
    • Kim, Hyo-Soo;
    • Kim, Young Jo;
    • Cho, Myeong Chan;
    • Kim, Chong Jin;
    • Jeong, Myung Ho;
    • Lee, Dae Ho;
    • Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) investigators
    Publication type:
    journal article
    2
    3
    4
    5

    A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.

    Published in:
    Endocrine Journal, 2015, v. 62, n. 5, p. 449, doi. 10.1507/endocrj.ej14-0544
    By:
    • Hae Kyung Yang;
    • Kyung Wan Min;
    • Sung Woo Park;
    • Choon Hee Chung;
    • Kyong Soo Park;
    • Sung Hee Choi;
    • Ki-Ho Song;
    • Doo-Man Kim;
    • Moon-Kyu Lee;
    • Yeon-Ah Sung;
    • Sei Hyun Baik;
    • In Joo Kim;
    • Bong-Soo Cha;
    • Jeong Hyun Park;
    • Yu Bae Ahn;
    • In-Kyu Lee;
    • Soon Jib Yoo;
    • Jaetaek Kim;
    • Ie Byung Park;
    • Tae Sun Park
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2743, doi. 10.1111/dom.15164
    By:
    • Park, Hyeong Kyu;
    • Kim, Kyoung‐Ah;
    • Min, Kyung‐Wan;
    • Sohn, Tae‐Seo;
    • Jeong, In Kyung;
    • Ahn, Chul Woo;
    • Kim, Nan‐Hee;
    • Park, Ie Byung;
    • Cho, Ho Chan;
    • Chung, Choon Hee;
    • Choi, Sung Hee;
    • Park, Kang Seo;
    • Yang, Seoung‐Oh;
    • Lee, Kwan Woo
    Publication type:
    Article
    31
    32
    33
    34
    35

    Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis.

    Published in:
    Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2019, v. 12, p. 1161, doi. 10.2147/DMSO.S209938
    By:
    • Lee, Kiyoung;
    • Park, Ie Byung;
    • Yu, Seung Hee;
    • Kim, Soo-Kyung;
    • Kim, So Hun;
    • Seo, Da Hea;
    • Hong, Seongbin;
    • Jeon, Ja Young;
    • Kim, Dae Jung;
    • Kim, Soo Wan;
    • Choi, Cheol Soo;
    • Lee, Dae Ho
    Publication type:
    Article
    36
    37
    38
    39